BFCH Closes Ancient Extracts USA Acquisition, Accelerating UNLOCKD's Transition Into Scalable Wellness Platform

BitFrontier Capital Holdings (BFCH) completes acquisition of VerdaGenix LLC, adding Ancient Extracts USA's DTC and retail wellness platform to accelerate its long-term growth strategy.

DC Metrowire Staff
Business
BFCH Closes Ancient Extracts USA Acquisition, Accelerating UNLOCKD's Transition Into Scalable Wellness Platform

BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc., announced the successful closing of its acquisition of VerdaGenix, LLC, owner and operator of the Ancient Extracts USA wellness platform. The acquisition adds an established direct-to-consumer (DTC) infrastructure, commercial operations, proprietary formulations, intellectual property, supplier relationships, inventory, fulfillment capabilities, digital marketing systems, and a catalog of over 20 wellness SKUs already in the market. Management believes this milestone significantly de-risks the Company’s broader operating strategy by establishing an active commercial foundation for future growth.

The transaction follows a series of strategic developments over the past year, including elimination of over $2 million in legacy convertible debt, balance sheet strengthening, restoration of disclosure compliance, acquisition of the EVERMIND™ intellectual property platform, and expansion of executive leadership. BFCH stated that the Company is now transitioning Ancient Extracts into a commercialization and expansion phase, focusing on scaling both DTC operations and retail distribution opportunities. The Company is advancing growth capital initiatives to support inventory expansion, operational scaling, customer acquisition, and retail channel development.

John P. Gorst, CEO of BFCH, emphasized that Ancient Extracts is not a concept being built from scratch but an operating business with existing infrastructure, commercialized products, customers, and distribution channels. He noted that the products align with long-term wellness and human optimization trends, and the focus is now on execution and building a significantly larger platform. Jordan P. Balencic, D.O., Chairman and Chief Science Officer, described the closing as a transformational milestone, shifting the Company’s focus from corporate restructuring toward commercialization, operational execution, and strategic expansion.

The Company also confirmed that management continues evaluating additional acquisition opportunities and strategic partnerships aligned with its long-term strategy. Separately, BFCH received a legal opinion that it is not a shell company under Rule 405 of the Securities Act of 1933, based on its operating strategy and asset base. For more information, visit www.UNLOCKDinc.com and view current filings on OTC Markets.

Blockchain Registration

QR Code for Blockchain Registration